Venture capital firm

Apposite Capital

Private equity investor for UK and European healthcare and life sciences small and medium-sized companies

Write a review

Medical
Dental
Healthtech
Biotech
+1 more

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

Apposite Capital is a private equity firm that invests only in healthcare and life sciences across the UK and Europe. It acts as the first institutional investor in small and medium-sized health companies and stays involved as they grow.

What Apposite Capital offers

Growth capital: funds expansion into new markets, products or therapeutic areas.
Management buyouts and buy-ins: backs changes of ownership led by managers.
Retirement sales and founder transitions: helps owners plan succession.
Buy-and-build support: assists with add-on acquisitions, debt raising and M&A.
Operational help: recruits senior talent and advisers, and supports digital change.

Customers and markets

Healthcare and life sciences SMEs, including medtech, health and social care, diagnostics, laboratory automation and dental practices. It also seeks investors as limited partners.

Key facts

Focus regions: UK and Europe
Sectors: healthcare and life sciences
Mission: better healthcare through quality, access and innovation

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Categories & features

Medical
Dental
Healthtech
Biotech
London

Rankings

Apposite Capital is ranked on 2 TrustList rankings: #25 on 1 and #42 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Apposite Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#25of 79
Biotech investors
It is the only one of the top 65 here listing dental and one of 10 here listing medical.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind Anthill Ventures, ahead of Baird Capital.
#42of 147
Healthtech investors
It is one of 14 here listing biotech.
Of the top 64 here, 16 also cover partners and 14 also cover biotech; 10 also work in New York City and 7 also work in Chicago.
Behind Aphelion Capital, ahead of Asahi Kasei.